ReviewBritish journal of cancer2020
Rationale for concurrent chemoradiotherapy for patients with stage III non-small-cell lung cancer.
John Conibear et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this paperpooled itcites it